Deferasirox prevents progression of non-alcoholic steatohepatitis in a mouse model with inhibition of heaptic fibrosis and hepatocellular ballooning

被引：0
|
作者：
Korenaga, Masaaki [1 ]
Korenaga, Keiko [1 ]
Mizokami, Masashi [1 ]
Kanto, Tatsuya [1 ]
机构：
[1] Natl Ctr Global Hlth & Med NCGM Kohnodai, Res Ctr Hepstitis & Immunol, Ichikawa, Japan
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1583
引用
收藏
页码：785A / 786A
页数：2
相关论文
共 50 条
  • [21] A Novel Mouse Model of Accelerated Non-Alcoholic Steatohepatitis
    Malhotra, P.
    Han, E.
    Ooka, K.
    Muthusamy, S.
    Gill, R.
    Dudeja, P.
    Aloman, C.
    Alrefai, W.
    FASEB JOURNAL, 2015, 29
  • [22] Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mouse
    Willebrords, J.
    Pereira, I. V. A.
    da Silva, T. C.
    Govoni, V. M.
    Maes, M.
    Yanguas, S. C.
    Rodrigues, R. M.
    Decrock, E.
    Leybaert, L.
    Leclercq, I.
    Cogliati, B.
    Vinken, M.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S432 - S432
  • [23] Chemerin in a Mouse Model of Non-alcoholic Steatohepatitis and Hepatocarcinogenesis
    Haberl, Elisabeth M.
    Pohl, Rebekka
    Rein-Fischboeck, Lisa
    Feder, Susanne
    Sinal, Christopher J.
    Buechler, Christa
    ANTICANCER RESEARCH, 2018, 38 (05) : 2649 - 2657
  • [24] Quantitation of fibrosis as a marker of disease progression in non-alcoholic steatohepatitis.
    Fraser-Moodie, CA
    Jenkins, D
    Gray, T
    Ryder, SD
    GUT, 2000, 46 : A61 - A61
  • [25] Filamin A is overexpressed in non-alcoholic steatohepatitis and contributes to the progression of inflammation and fibrosis
    Lu, Ying
    Wang, Mengzhu
    Zhao, Manyu
    Zhang, Qianru
    Qian, Rui
    Hu, Zan
    Ke, Qi
    Yu, Lin
    Wang, Liqun
    Lai, Qinhuai
    Liu, Zhenmi
    Jiang, Xia
    Zhang, Ben
    Yang, Jinliang
    Yao, Yuqin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 653 : 93 - 101
  • [26] Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
    Argo, Curtis K.
    Northup, Patrick G.
    Al-Osaimi, Abdullah M. S.
    Caldwell, Stephen H.
    JOURNAL OF HEPATOLOGY, 2009, 51 (02) : 371 - 379
  • [27] Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis
    Waghorn, Philip A.
    Ferreira, Diego S.
    Erstad, Derek J.
    Rotile, Nicholas J.
    Masia, Ricard
    Jones, Chloe M.
    Tu, Chuantao
    Sojoodi, Mozhdeh
    Chen, Yin-ching, I
    Schlerman, Franklin
    Wellen, Jeremy
    Martinez, Robert V. P.
    Tanabe, Kenneth K.
    Fuchs, Bryan C.
    Caravan, Peter
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [28] Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model
    Aoyama, Yoshinaga
    Naiki-Ito, Aya
    Xiaochen, Kuang
    Komura, Masayuki
    Kato, Hiroyuki
    Nagayasu, Yuko
    Inaguma, Shingo
    Tsuda, Hiroyuki
    Tomita, Mamoru
    Matsuo, Yoichi
    Takiguchi, Shuji
    Takahashi, Satoru
    NUTRIENTS, 2022, 14 (01)
  • [29] Centrilobular ductular reaction correlates with fibrosis stage and fibrosis progression in non-alcoholic steatohepatitis
    Zhao, Lei
    Westerhoff, Maria
    Pai, Rish K.
    Choi, Won-Tak
    Gao, Zu-Hua
    Hart, John
    MODERN PATHOLOGY, 2018, 31 (01) : 150 - 159
  • [30] PROFILING FIBROSIS REGRESSION IN A RAT MODEL OF NON-ALCOHOLIC STEATOHEPATITIS
    Schaub, Johanna
    Lee, Gail
    Jenkins, Katherine
    Chen, Tony
    Martin, Shamra
    Rao, Vikram
    Marlow, Megan
    Ho, Steve
    Decaris, Martin
    Chen, Chun
    Turner, Scott
    HEPATOLOGY, 2020, 72 : 212A - 212A
12345